本页面由Tiger Trade Technology Pte. Ltd.提供服务

Contineum Therapeutics, INC.

14.06
-0.3100-2.16%
盘后14.060.00000.00%19:34 EDT
成交量:12.28万
成交额:173.37万
市值:5.25亿
市盈率:-7.35
高:14.45
开:14.45
低:13.78
收:14.37
52周最高:16.91
52周最低:5.07
股本:3,733.60万
流通股本:2,759.08万
量比:0.67
换手率:0.45%
股息:- -
股息率:- -
每股收益(TTM):-1.9138
每股收益(LYR):-2.1700
净资产收益率:-26.88%
总资产收益率:-18.18%
市净率:2.10
市盈率(LYR):-6.48

数据加载中...

2026/07/17

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/14

重要事件披露

Form 8-K - Current report
2026/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/26

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/05

重要事件披露

Form 8-K - Current report
2026/05/05

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

重要事件披露

Form 8-K - Current report
2026/04/17

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/05

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/05

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/03/05

重要事件披露

Form 8-K - Current report